About: Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on January 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) bài báo khoa học (vi) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в січні 2008 (uk) scientific article published on January 2008 (en) مقالة علمية نشرت في يناير 2008 (ar)
publication date	wds:Q37101735-26D1F093-3E5C-4412-B6EC-2DFC39B027C6
publication date	2008-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q37101735-2DD0DFB9-F262-4F3B-8232-1AD98F70CD1B wds:Q37101735-35DFB0E2-711B-4168-8DBF-FA60C4AE2348 wds:Q37101735-6258E0E5-B23C-4C83-BE1C-2AC3E862DB5B wds:Q37101735-6C6DB7B7-49AC-43B8-8ADB-CD49AAB733DA wds:Q37101735-7E51F9B7-42E4-4301-935C-1AFC44C65300 wds:Q37101735-B4C2F106-CF0C-47A7-8EED-9112A677AF5B wds:Q37101735-DBDD357A-817C-4126-A9CA-479627B8F394 wds:Q37101735-E52767F4-51E7-4DE2-A7ED-EAD0060120D6 wds:Q37101735-EC410CB8-A4F3-4B0D-8BE7-8F8C9440BBA7
cites work	Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story? Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents An 11-year-old boy with drug-resistant schizophrenia treated with temporo-parietal rTMS. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). Obesity and the metabolic syndrome in children and adolescents Metabolic risk during antipsychotic treatment Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain? Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management Children with schizophrenia: clinical picture and pharmacological treatment.
author name string	wds:Q37101735-3990BC1F-83AF-4BF2-AE70-4592C759814A wds:Q37101735-530E61F7-C361-454F-B412-CECAEF2D811F wds:Q37101735-53BE1B67-DF58-443F-8696-CF2500D31327 wds:Q37101735-7A5B517F-0ECC-4EFC-9ADA-5CF4176FD5F3 wds:Q37101735-911155FF-6A57-4B6B-8A41-42826E48F82E wds:Q37101735-DA2C7E46-6ACF-4682-A976-9915C809A6DE
author name string	Régis Bordet Alain Duhamel Pierre Thomas Jean-Louis Goëb Geraldine Kechid Sophie Marco
rdfs:label	Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (en) Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (nl) Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (ast)
skos:prefLabel	Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (en) Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (nl) Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (ast)
name	Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (en) Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (nl) Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (ast)
author	wds:Q37101735-16D68ED6-8DB4-4E69-B384-1D97DC25E4DE wds:Q37101735-ACF600D6-AA62-4019-87F9-9DFC119634F2
author	Pierre Delion Renaud Jardri
title	wds:Q37101735-3EFE1C5E-C40C-4106-BA76-D747169EF2DA
title	Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia (en)
page(s)	wds:Q37101735-1638D573-15C7-4B9B-8352-BDE8CC49A8A6
page(s)	486-487
instance of	wds:Q37101735-76E6791A-F387-47A6-82FA-C24ABB2AC407
instance of	scholarly article
main subject	wds:Q37101735-B83E8235-2E92-4CBF-A11B-A7E2B3114819 wds:Q37101735-C007549F-F6A8-45EE-BF9C-4C656F4F2A44 wds:Q37101735-EEDA2370-D494-4CC6-8F48-BA517ED606D2
main subject	teenager schizophrenia risperidone
PubMed ID	wds:Q37101735-C03E3137-9D60-41B5-BCD4-6E91A904672B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19287568
PubMed ID	19287568
published in	wds:Q37101735-3F392E60-2F36-4D12-8393-D9B92DB80743
published in	Primary Care Companion to the Journal of Clinical Psychiatry
issue	wds:Q37101735-37F03561-7438-4F82-8994-0638DDA00956
volume	wds:Q37101735-B26EB434-8E93-42B0-A8F2-FCF964038A73
issue	6
volume	10
DOI	wds:Q37101735-F5AE988E-8920-496D-891E-6FAD8EA0B43A
DOI	http://dx.doi.org/10.4088/PCC.V10N0612H
DOI	10.4088/PCC.V10N0612H
PMCID	wds:Q37101735-46C3C190-27F1-4496-BB6F-0EB7088F44A7
PMCID	2644486
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37101735
is cites work of	Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk
is cites work of	wds:Q31090636-D75F4479-A12C-418E-A692-29988453FFA5 wds:Q31147850-5CB96FFB-9171-4E9C-AFD0-7B19F11EEC1D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software